EcoDrugPlus

Eph Receptor A3

Ensembl ID : ENSCHOG00000001500
Gene Symbol: EPHA3
1 Cross references
216 Possible Orthologues:

Fyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSCHOG00000012780
Gene Symbol: FYN
1 Cross references
264 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSCHOG00000009531
Gene Symbol: ITK
1 Cross references
208 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSCHOG00000007686
Gene Symbol: JAK1
1 Cross references
238 Possible Orthologues:

Kit Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSCHOG00000006451
Gene Symbol: KIT
1 Cross references
211 Possible Orthologues:

Lyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSCHOG00000011290
Gene Symbol: LYN
1 Cross references
197 Possible Orthologues:

Malt1 Paracaspase

Ensembl ID : ENSCHOG00000013488
Gene Symbol: MALT1
1 Cross references
197 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSCHOG00000005254
Gene Symbol: MET
1 Cross references
207 Possible Orthologues:

Mpl Proto-Oncogene, Thrombopoietin Receptor

Ensembl ID : ENSCHOG00000008055
Gene Symbol: MPL
1 Cross references
186 Possible Orthologues:

Nad(P)h Quinone Dehydrogenase 1

Ensembl ID : ENSCHOG00000013421
Gene Symbol: NQO1
1 Cross references
195 Possible Orthologues:

Nfe2 Like Bzip Transcription Factor 2

Ensembl ID : ENSCHOG00000005792
Gene Symbol: NFE2L2
1 Cross references
216 Possible Orthologues:

Pim-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSCHOG00000010799
Gene Symbol: PIM1
1 Cross references
248 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).